...
首页> 外文期刊>Journal of Cancer >Prognostic value of CEA/CA72-4 immunohistochemistry in combination with cytology for detecting tumor cells in peritoneal lavage in gastric cancer
【24h】

Prognostic value of CEA/CA72-4 immunohistochemistry in combination with cytology for detecting tumor cells in peritoneal lavage in gastric cancer

机译:CEA / CA72-4免疫组织化学与细胞学中的预后价值在胃癌腹膜灌洗中检测肿瘤细胞的细胞学

获取原文
           

摘要

Aim: To study the value and efficiency of CEA/CA72-4 immunohistochemistry in detecting free tumor cells from peritoneal lavage, in order to provide reliable lab information for subsequent intraperitoneal chemotherapy. Methods: A total of 112 progressive gastric cancer patients were enrolled from Oct. 2016 to Oct 2017, who were pathologically diagnosed as gastric cancer after surgery. Peritoneal lavage was respectively collected during operation. Cytology and CEA/CA72-4 immunohistochemistry of peritoneal lavage samples was performed. Overall survival and recurrence free survival was analyzed. Results: Cytology showed 16 positive cases (14.29%), CEA immunohistochemistry showed 29 positive cases (25.89%), CA72-4 immunohistochemistry showed 33 positive cases (29.46%). McNemar's test showed significant difference in positivity between cytology (CY ) and CEA/CA72-4 immunohistochemistry (IHC ). Kappa test showed consistency between immunohistochemistry of CEA and CA72-4 with cytology. Patients with CY /IHC had the poorest overall survival (OS) as well as recurrence free survival (RFS), followed by those with CY or IHC , while those with CY-/IHC- had higher OS and RFS. The differences of OS and RFS in IHC group were worse than that in IHC- group. Kaplan-Meier analysis showed that positive CEA/CA72-4 IHC revealed poorer prognosis than the negative cases. Conclusions: Due to the limitation of cytology, combination of cytology and immunohistochemistry appears to be more efficient for predicting prognosis of progressive gastric cancer.? The author(s).
机译:目的:研究CEA / CA72-4免疫组织化学在腹膜灌洗中检测自由肿瘤细胞的价值和效率,以便为随后的腹膜内化疗提供可靠的实验室信息。方法:从2016年10月到2017年10月,共有112名逐步胃癌患者,他们在手术后病理诊断为胃癌。在操作期间分别收集腹膜灌洗液。进行细胞学和CEA / CA72-4腹膜灌洗样品的免疫组化。分析了整体存活和复发存活。结果:细胞学显示出16例阳性病例(14.29%),CEA免疫组化显示29例阳性病例(25.89%),CA72-4免疫组化显示33例阳性病例(29.46%)。麦克纳玛尔的测试显示细胞学(CY)和CEA / CA72-4免疫组织化学(IHC)之间的阳性差异。 Kappa试验显示CEA和CA72-4与细胞学的免疫组织化学之间的一致性。 CY / IHC患者具有最贫困的总体存活率(OS)以及复发自由存活(RFS),其次是含CY或IHC的患者,而具有含CY- / IHC的那些患者具有更高的OS和RF。 IHC组OS和RFS的差异比IHC-Group在IHC组中的差异。 Kaplan-Meier分析表明,阳性CEA / CA72-4 IHC揭示了比负病例更差。结论:由于细胞学的限制,细胞学和免疫组织化学的组合似乎更有效地预测渐进胃癌的预后更有效。作者。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号